Article · 16 Sep 2026
Conference abstract
Development, characterization, and in-vivo assessment of dual targeted nanoparticles for the delivery of anti-cancer drug to glioma cell
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Glioblastoma multiform (GBM), is characterized by high proliferation rate, migration, invasion as well as secretion of angiogenetic factors. Effective chemotherapy for glioblastoma requires a smart nanocarrier that can penetrate the blood brain barrier (BBB) and subsequently target the glioma cells. In the study, dual-targeting paclitaxel (Ptx) polymeric nanoparticles (NPs) were produced by conjugating with both folate (FA) and cRGDfK, for the effective penetrating across BBB and targeting glioma, respectively. FA and cRGDfK modified NPs containing paclitaxel was prepared by nanoprecipitation technique combined with selfassembly. The PLNs was characterized by particle size, shape, zeta potential, entrapment efficiency, in vitro release profile, cytotoxicity, hemolysis study, cell uptake, in vitro transendothelial transport in brain endothelial cell lines. In vitro and in vivo studies demonstrated that the dual-targeting NPs could transport across the BBB and mainly distributed in the brain glioma. FA and cRGDfk conjugated NPs had maximum entrapment efficiency 81.34?3.41% (n=3). AFM showed NPs to be spherical and nanometric in size. The in vitro release followed in a biphasic pattern: i.e., an initial burst release followed by slower and sustained release and resulted in least haemolytic toxicity. The anti-tumor effect of the dual-targeting NPs also demonstrated increased survival time, decreased tumor volume and no significant effect on body weight. The dual-targeted NPs could improve the therapeutic efficacy of brain glioma and were found less toxic than the Ptx solution, showing a dual-targeting effect. These results indicate that dual-targeting NPs are promising potential carrier for glioma chemotherapy.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Udita Agrawal”
- BylineArticles whose byline prints “S P Vyas”
